102 related articles for article (PubMed ID: 38954260)
1. Ginkgolide C attenuated Western diet-induced non-alcoholic fatty liver disease via increasing AMPK activation.
Xie Y; Wei L; Guo J; Jiang Q; Xiang Y; Lin Y; Xie H; Yin X; Gong X; Wan J
Inflammation; 2024 Jul; ():. PubMed ID: 38954260
[TBL] [Abstract][Full Text] [Related]
2. A non-mitogenic FGF4 analog alleviates non-alcoholic steatohepatitis through an AMPK-dependent pathway.
Wang L; Dong W; Gao H; Chen C; Liang S; Ye X; Liu Y; Hou Y; Fan L; Pan T; Wang Z; Chen Y; Luo Y; Song L
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166560. PubMed ID: 36167161
[TBL] [Abstract][Full Text] [Related]
3. Extracts of Vine Tea Improve Diet-Induced Non-Alcoholic Steatohepatitis Through AMPK-LXRα Signaling.
Chen YJ; Song HY; Zhang ZW; Chen Q; Tang ZP; Gu M
Front Pharmacol; 2021; 12():711763. PubMed ID: 34393793
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway.
Lan T; Yu Y; Zhang J; Li H; Weng Q; Jiang S; Tian S; Xu T; Hu S; Yang G; Zhang Y; Wang W; Wang L; Zhu Q; Rong X; Guo J
Hepatology; 2021 Aug; 74(2):686-703. PubMed ID: 33576035
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
[TBL] [Abstract][Full Text] [Related]
7. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
[TBL] [Abstract][Full Text] [Related]
8. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH.
Zanieri F; Levi A; Montefusco D; Longato L; De Chiara F; Frenguelli L; Omenetti S; Andreola F; Luong TV; Massey V; Caballeria J; Fondevila C; Shanmugavelandy SS; Fox T; Mazza G; Argemi J; Bataller R; Cowart LA; Kester M; Pinzani M; Rombouts K
Cells; 2020 May; 9(5):. PubMed ID: 32429478
[TBL] [Abstract][Full Text] [Related]
9. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
10. Asperuloside alleviates lipid accumulation and inflammation in HFD-induced NAFLD via AMPK signaling pathway and NLRP3 inflammasome.
Shen Q; Chen Y; Shi J; Pei C; Chen S; Huang S; Li W; Shi X; Liang J; Hou S
Eur J Pharmacol; 2023 Mar; 942():175504. PubMed ID: 36641101
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis.
Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L
Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488
[TBL] [Abstract][Full Text] [Related]
12. β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats.
Luo H; Xu N; Wu J; Gan Y; Chen L; Guan F; Li M; Li Y; Chen J; Su Z; Liu Y
Int Immunopharmacol; 2021 Sep; 98():107915. PubMed ID: 34198236
[TBL] [Abstract][Full Text] [Related]
13. Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.
Wan J; Zhang Y; Yang D; Liang Y; Yang L; Hu S; Liu Z; Fang Q; Tian S; Ding Y
Hepatology; 2021 Dec; 74(6):3074-3090. PubMed ID: 34297426
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
[TBL] [Abstract][Full Text] [Related]
15. Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity.
Rao Y; Lu YT; Li C; Song QQ; Xu YH; Xu Z; Hu YT; Yu H; Gao L; Gu LQ; Ye JM; Huang ZS
Br J Pharmacol; 2019 Aug; 176(16):2877-2893. PubMed ID: 31113010
[TBL] [Abstract][Full Text] [Related]
16. Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis.
Gluais-Dagorn P; Foretz M; Steinberg GR; Batchuluun B; Zawistowska-Deniziak A; Lambooij JM; Guigas B; Carling D; Monternier PA; Moller DE; Bolze S; Hallakou-Bozec S
Hepatol Commun; 2022 Jan; 6(1):101-119. PubMed ID: 34494384
[TBL] [Abstract][Full Text] [Related]
17. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
18. β-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway.
Xu N; Luo H; Li M; Wu J; Wu X; Chen L; Gan Y; Guan F; Li M; Su Z; Chen J; Liu Y
Biomed Pharmacother; 2021 Feb; 134():111104. PubMed ID: 33341045
[TBL] [Abstract][Full Text] [Related]
19. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway.
Zhang L; Li HX; Pan WS; Khan FU; Qian C; Qi-Li FR; Xu X
Biomed Pharmacother; 2019 Feb; 110():571-581. PubMed ID: 30537674
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of genistein on the production performance and lipid metabolism disorders in laying hens with fatty liver hemorrhagic syndrome by activation of the GPER-AMPK signaling pathways.
Li L; Wang Y; Wang H; Yang Y; Ma H
J Anim Sci; 2023 Jan; 101():. PubMed ID: 37314978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
